CHICAGO, Nov 27, 2001 (BW HealthWire) -- Varian Medical Systems, Inc. (NYSE: VAR) today announced that Hologic, Inc. (NASDAQ: HOLX) will incorporate Varian's Integral(TM)Mammo tube into the LORAD Affinity Mammography System. The system is on display at the Radiological Society of North America (RSNA) meeting here this week.
The LORAD Affinity is a high-performance screen-film mammography system specifically developed to fill a market need for a cost-effective product with performance characteristics similar to high-end systems.
"Varian's oil-free Integral Mammo tube was designed to address safety and high image quality in systems that can serve more patients per day, so it fit well into the Affinity system" said Steve Clark, vice president of marketing for Varian Medical Systems' X-ray Products business. "The Integral Mammo tube provides the LORAD Affinity mammography system with improved operating parameters, particularly a high heat dissipation rate, a more compact size, quiet performance, and the ability to exceed the industry-standard for resolution."
"We believe our Affinity Mammography System provides a highly effective solution for value-driven customers seeking a quality product to meet their mammography needs," said Pete Kershaw, vice president and general manager of LORAD. "The introduction of this versatile system to the mammography community provides effective, expanded choices for this market niche and advances LORAD's commitment to improving women's healthcare by producing high-quality products for the early detection of breast cancer."
Varian Medical Systems, Inc., (NYSE:VAR) of Palo Alto, California, is the world's leading manufacturer of integrated cancer therapy systems as well as X-ray tubes and flat-panel sensors for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 2,600 people and reported sales of $774 million in its most recent fiscal year ended September 28, 2001. The company's X-ray Products business unit is based in Salt Lake City. For more information, visit www.varian.com.
Hologic, Inc. (NASDAQ: HOLX) is dedicated to developing and delivering proprietary X-ray systems that incorporate direct-to-digital radiographic imaging technology for both women's health and general radiographic applications. Hologic's business divisions include Hologic Osteoporosis Assessment, a provider of premier bone densitometry systems, Hologic Radiographic Systems, encompassing general and digital radiography systems, and the wholly-owned subsidiaries: Direct Radiography Corp., a manufacturer of state-of-the-art proprietary flat panel technology called DirectRay; Fluoroscan Imaging, a manufacturer of low intensity, real time X-ray imaging devices; and LORAD, specializing in innovative mammography and minimally invasive breast biopsy systems.